Eloxx Pharmaceuticals, Inc. (ELOX) SEC filings
ELOX SEC filings moved a median of 0.00% by the close. ELOX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ELOX overview →
33 measured ELOX SEC filing events.
Where these ELOX SEC filings landedvs 23 measured ELOX SEC filing reactions
| Middle 50% of ELOX SEC filing reactions | -2.99% to 0.00% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 23 |
Point-in-time · zero look-ahead
Half of the 23 ELOX SEC filing events with a measured close landed between -2.99% and +0.00%; 22% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form EFFECT Eloxx Pharmaceuticals, | SEC filing · Form EFFECT | +5.12% | -0.98% | |
| Form S-1 Eloxx Pharmaceuticals, | SEC filing · Form S-1 | +0.00% | +5.84% | |
| Form 10-Q Eloxx Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -0.04% | -7.85% | |
| Form 8-K Eloxx Pharmaceuticals, For: Aug 11 | SEC filing · Form 8-K | -0.04% | -7.85% | |
| Form 8-A12B Eloxx Pharmaceuticals, | SEC filing · Form 8-A12B | — | — | |
| Form 8-K Eloxx Pharmaceuticals, For: May 27 | SEC filing · Form 8-K | — | — | |
| Form S-1/A Eloxx Pharmaceuticals, | SEC filing · Form S-1 | — | — | |
| Form DEF 14C Eloxx Pharmaceuticals, For: May 08 | SEC filing · Form DEF | +0.00% | +0.00% | |
| Form S-1 Eloxx Pharmaceuticals, | SEC filing · Form S-1 | — | — | |
| Form 10-Q Eloxx Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +2.86% | -25.71% | |
| Form 8-K Eloxx Pharmaceuticals, For: Apr 28 | SEC filing · Form 8-K | +3.48% | -0.77% | |
| Form PRE 14C Eloxx Pharmaceuticals, For: Apr 28 | SEC filing · Form PRE | +0.00% | +0.00% | |
| Form 10-K Eloxx Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Jun 30 | SEC filing · Form NT | — | — | |
| Form 8-K Eloxx Pharmaceuticals, For: Aug 06 | SEC filing · Form 8-K | — | — | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Mar 31 | SEC filing · Form NT | +0.00% | +0.00% | |
| Form NT 10-K Eloxx Pharmaceuticals, For: Dec 31 | SEC filing · Form NT | — | — | |
| Form SEC STAFF ACTION Eloxx Pharmaceuticals, | SEC filing · Form SEC | — | +0.00% | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Sep 30 | SEC filing · Form NT | — | — | |
| Form 8-K Eloxx Pharmaceuticals, For: Oct 16 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Jun 30 | SEC filing · Form NT | — | — | |
| Form 8-K Eloxx Pharmaceuticals, For: Jul 10 | SEC filing · Form 8-K | — | — | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Mar 31 | SEC filing · Form NT | +0.00% | +0.32% | |
| Form NT 10-K Eloxx Pharmaceuticals, For: Dec 31 | SEC filing · Form NT | +0.00% | +2.04% | |
| Form 8-K Eloxx Pharmaceuticals, For: Mar 25 | SEC filing · Form 8-K | +0.00% | +2.00% | |
| Form 8-K Eloxx Pharmaceuticals, For: Mar 11 | SEC filing · Form 8-K | +0.00% | -2.65% | |
| Form S-3 Eloxx Pharmaceuticals, | SEC filing · Form S-3 | -0.06% | -0.06% | |
| Form S-8 Eloxx Pharmaceuticals, | SEC filing · Form S-8 | -0.06% | -0.06% | |
| Form 8-K Eloxx Pharmaceuticals, For: Jan 09 | SEC filing · Form 8-K | -1.46% | -3.33% | |
| Form 8-K Eloxx Pharmaceuticals, For: Dec 27 | SEC filing · Form 8-K | +8.70% | +4.35% | |
| Form 8-K Eloxx Pharmaceuticals, For: Dec 15 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q Eloxx Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.59% | -7.79% | |
| Form 8-K Eloxx Pharmaceuticals, For: Nov 13 | SEC filing · Form 8-K | +0.59% | -7.79% |
Keep exploring
More ELOX: earnings → · analyst actions → · ELOX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| UCB SA UNSP/ADR (UCBJY) | 85 | +0.00% | 51% |
| NUO THERAPEUTICS INC NEW (AURX) | 84 | 0.00% | 24% |
| Knight Therapeutics Inc (GUD_TSE) | 84 | 0.00% | 40% |
| Molecular Templates, Inc. (MTEM) | 84 | -0.48% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.